50% off the $29.99 Custom Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AEO Score: 4/10
Monitoring for AI engine activity
In the Engagemii AEO index
#306,191 of 453,159 in Healthcare for AI visibility
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Ohtuvayre HCP just got measured.
4/10 means Ohtuvayre HCP is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
Discover OHTUVAYRE (ensifentrine) inhalation suspension, for oral inhalation – novel first-in-class selective dual inhibitor of phosphodiesterase (PDE) 3 and PDE4, offering a nonsteroidal approach to bronchodilation and anti-inflammation for persistently symptomatic COPD patients.
Industry: Healthcare
ohtuvayhcp.com3
Structured Data
4
Content Structure
7
Entity Clarity
2
E-E-A-T Signals
6
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Ohtuvayre HCP.
Scored by Engagemii on July 11, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/ohtuvayhcp
Cite this score: Engagemii (2026). "AEO Score for Ohtuvayre HCP." Retrieved from https://engagemii.com/aeo/brands/ohtuvayhcp
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform